Division of Immunology, Department of Pathology, University of Cambridge, Cambridge, UK.
Eur J Immunol. 2011 Dec;41(12):3667-76. doi: 10.1002/eji.201141645. Epub 2011 Nov 3.
MICA and MICB (MHC-class-I-related chain A/B) are transmembrane proteins expressed in pathological conditions that are ligands for NKG2D, an activating receptor found on cytotoxic lymphocytes. The recognition on target cells of NKG2D ligands leads to the activation of lysis and cytokine secretion by NK cells and T cells. Besides being expressed at the cell surface, MICA/B can be released as soluble proteins. Soluble NKG2D ligands downmodulate expression of the NKG2D receptor on lymphocytes, leading to a diminished cytotoxic response. Prior studies suggested that recruitment of MICA/B molecules to cholesterol-enriched microdomains was an important factor regulating the proteolytic release of these molecules. We now show that recruitment of MICA to these microdomains depends on palmitoylation of two cysteine residues that allow MICA molecules to reside in the membrane in the same domains as caveolin-1. Compared with WT molecules, nonpalmitoylated mutant MICA molecules were shed to the supernatant with low efficiency; however, both WT and mutant MICA were able to trigger NK cell cytotoxicity. These data suggest that the presence of NKG2D ligands at the plasma membrane is sufficient to activate cytotoxicity and reflect the need of different ligands to exploit different cellular pathways to reach the cell surface upon different stress situations.
MICA 和 MICB(MHC Ⅰ类相关链 A/B)是在病理条件下表达的跨膜蛋白,它们是 NKG2D 的配体,NKG2D 是细胞毒性淋巴细胞上的一种激活受体。NKG2D 配体在靶细胞上的识别导致 NK 细胞和 T 细胞的裂解和细胞因子分泌的激活。除了在细胞表面表达外,MICA/B 还可以作为可溶性蛋白释放。可溶性 NKG2D 配体下调淋巴细胞上 NKG2D 受体的表达,导致细胞毒性反应减弱。先前的研究表明,MICA/B 分子向富含胆固醇的微区的募集是调节这些分子蛋白水解释放的重要因素。我们现在表明,MICA 向这些微区的募集依赖于两个半胱氨酸残基的棕榈酰化,这允许 MICA 分子与质膜中的小窝蛋白-1 位于同一结构域中。与 WT 分子相比,非棕榈酰化的突变 MICA 分子以低效率分泌到上清液中;然而,WT 和突变 MICA 都能够触发 NK 细胞的细胞毒性。这些数据表明,质膜上存在 NKG2D 配体足以激活细胞毒性,并反映了不同的配体需要利用不同的细胞途径在不同的应激情况下到达质膜。